Results 1 to 10 of about 37,695 (50)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases

Microorganisms, 2021
Inflammatory bowel diseases (IBDs) are a group of chronic gastrointestinal inflammatory diseases with unknown etiology. There is a combination of well documented factors in their pathogenesis, including intestinal microbiota dysbiosis.
Valerio Baldelli, F. Scaldaferri, L. Putignani, F. Del Chierico   +3 more
semanticscholar   +1 more source

Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets

Frontiers in Cellular and Infection Microbiology, 2022
Objectives A number of converging strands of research suggest that the intestinal Enterobacteriaceae plays a crucial role in the development and progression of inflammatory bowel disease (IBD), however, the changes in the abundance of Enterobacteriaceae ...
Babak Khorsand, H. Asadzadeh Aghdaei, E. Nazemalhosseini-Mojarad, Bahareh Nadalian, B. Nadalian, H. Houri   +5 more
semanticscholar   +1 more source

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

Infection and Drug Resistance, 2021
Infections due to multidrug-resistant Enterobacteriaceae have become major international public health problem due to the inadequate treatment options and the historically lagged pace of development of novel antimicrobial drugs.
M. Tilahun, Y. Kassa, A. Gedefie, Melaku Ashagire   +3 more
semanticscholar   +1 more source

The Changing Face of the Family Enterobacteriaceae (Order: “Enterobacterales”): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and Disease Syndromes

Clinical Microbiology Reviews, 2021
The family Enterobacteriaceae has undergone significant morphogenetic changes in its more than 85-year history, particularly during the past 2 decades (2000 to 2020).
J. Janda, S. Abbott
semanticscholar   +1 more source

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

Journal of Infectious Diseases, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) are a serious public health threat. Infections due to these organisms are associated with significant morbidity and mortality.
L. Logan, R. Weinstein
semanticscholar   +1 more source

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

Frontiers in Microbiology, 2019
Carbapenems are considered as last-resort antibiotics for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in clinical practice, the emergence of carbapenem-resistant pathogens now ...
C. Sheu, Ya-Ting Chang, Shang-Yi Lin, Yen-Hsu Chen, P. Hsueh   +4 more
semanticscholar   +1 more source

Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae

Journal of Antimicrobial Chemotherapy, 2018
Bacterial antimicrobial resistance (AMR) is constantly evolving and horizontal gene transfer through plasmids plays a major role. The identification of plasmid characteristics and their association with different bacterial hosts provides crucial ...
M. Rozwandowicz, M. Brouwer, J. Fischer, Jaap A. Wagenaar, B. González-Zorn, B. Guerra, D. Mevius, Joost Hordijk   +7 more
semanticscholar   +1 more source

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

Clinical Microbiology Reviews, 2018
SUMMARY Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is challenging, and some of the few active drugs are not available in many countries.
J. Rodríguez-Baño, B. Gutiérrez-Gutiérrez, I. Machuca, Á. Pascual   +3 more
semanticscholar   +1 more source

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

Clinical Infectious Diseases, 2018
Background The efficacy of ceftazidime-avibactam-a cephalosporin-β-lactamase inhibitor combination with in vitro activity against Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CRE)-compared with colistin remains ...
D. van Duin, J. Lok, M. Earley, E. Cober, S. Richter, F. Pérez, R. Salata, R. Kalayjian, Richard Watkins, Y. Doi, K. Kaye, V. Fowler, D. Paterson, R. Bonomo, S. Evans   +14 more
semanticscholar   +1 more source

Detection and characterization of ESBL-producing Enterobacteriaceae from the gut of subsistence farmers, their livestock, and the surrounding environment in rural Nepal

Scientific Reports, 2021
The increasing trend of gut colonization by extended-spectrum β-lactamase (ESBL) producing Enterobacterales has been observed in conventional farm animals and their owners.
S. Subramanya, I. Bairy, Yang Metok, B. Baral, D. Gautam, N. Nayak   +5 more
semanticscholar   +1 more source